LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Torin1 | 0.12 | uM | LJP6 | 3 | O17 | 72 | hr | 1334 | 1652 | 3970 | 0.4160 | 0.1204 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 1 | I23 | 72 | hr | 1334 | 1210 | 3970 | 0.3047 | -0.0473 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 2 | I23 | 72 | hr | 1334 | 1127 | 3970 | 0.2838 | -0.0788 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 3 | I23 | 72 | hr | 1334 | 1218 | 3970 | 0.3067 | -0.0443 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 1334 | 1148 | 3970 | 0.2891 | -0.0708 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 1334 | 1196 | 3970 | 0.3012 | -0.0526 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 1334 | 1316 | 3970 | 0.3314 | -0.0071 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 1 | P23 | 72 | hr | 1334 | 3410 | 3970 | 0.8588 | 0.7872 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 2 | P23 | 72 | hr | 1334 | 3652 | 3970 | 0.9197 | 0.8790 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 3 | P23 | 72 | hr | 1334 | 3495 | 3970 | 0.8802 | 0.8195 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 1 | M05 | 72 | hr | 1334 | 4387 | 3970 | 1.1048 | 1.1578 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 2 | M05 | 72 | hr | 1334 | 4185 | 3970 | 1.0539 | 1.0812 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 3 | M05 | 72 | hr | 1334 | 4055 | 3970 | 1.0212 | 1.0319 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 1334 | 3523 | 3970 | 0.8872 | 0.8301 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 1334 | 3809 | 3970 | 0.9592 | 0.9386 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 1334 | 4094 | 3970 | 1.0310 | 1.0467 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 1 | G17 | 72 | hr | 1334 | 3214 | 3970 | 0.8094 | 0.7129 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 2 | G17 | 72 | hr | 1334 | 3807 | 3970 | 0.9587 | 0.9378 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 3 | G17 | 72 | hr | 1334 | 3800 | 3970 | 0.9570 | 0.9352 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 1 | G17 | 72 | hr | 1334 | 3997 | 3970 | 1.0066 | 1.0099 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 2 | G17 | 72 | hr | 1334 | 4260 | 3970 | 1.0728 | 1.1097 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 3 | G17 | 72 | hr | 1334 | 3882 | 3970 | 0.9776 | 0.9663 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 1 | L11 | 72 | hr | 1334 | 2352 | 3970 | 0.5923 | 0.3859 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 2 | L11 | 72 | hr | 1334 | 2128 | 3970 | 0.5359 | 0.3009 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 3 | L11 | 72 | hr | 1334 | 2045 | 3970 | 0.5150 | 0.2695 |